Molecular profiling of BRCA1/BRCA2 gene variants in Pakistani breast cancer patients
Journal of the Pakistan Medical Association · 2024
DOI: 10.47391/jpma.11098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, 2024. Verfasst von Bushra Ghulam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Islamic International Medical College, Rawalpindi, Pakistan;. Hauptthemen laut MEDLINE: Breast Neoplasms, BRCA1 Protein, BRCA2 Protein. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To determine the frequency of genetic variants in breast cancer types 1 and 2 gene in breast cancer Pakistani patients.
Method
The case-control study was conducted at the Islamic International Medical College and Pakistan Railway Hospital, Rawalpindi, Pakistan, from October 2022 to August 2023, and comprised females with breast cancer in group A, with an age range of 23–83 years (mean 51.9 years with SD ± 10.8 years) and as many healthy, age-matched female controls in group B, with age range of 26–82 years (mean 57.8 years with SD ±10.1 years). Peripheral blood samples were taken from all the participants. Allele-specific tetra amplification refractory mutation system-polymerase chain reaction was used to determine the frequency of c.4485G>A, c.4508C>A, c.5278G>C and c.5503C>T genetic variants in breast cancer type 1 gene, and c.92G>A and c.3109C>T genetic variants in breast cancer type 2 gene. Data was analysed using SPSS 27.
Results
Of the 336 female participants 168(50%) were in each of the 2 groups. None of the group B controls had genetic variants in breast cancer type 1 and 2 genes. In group A patients, 4(2.3%) had the variant c.4485G>A in breast cancer type 1 gene, while other breast cancer type 1 variants were negative. Also, 9(5.3%) group A patients had variants c.92G>A and c.3109C>T in breast cancer type 2 gene.
Conclusion
Cost-effective, polymerase chain reaction-based genetic testing could effectively identify mutant variants of breast cancer types 1 and 2 genes in the Pakistani population. Key Words: Breast cancer, BRCA1, BRCA2 genes, Allele-specific ARMS-PCR, Genetic testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Islamic International Medical College, Rawalpindi, Pakistan;.
- Department of Biological and Health Sciences, Pak-Austria Fachhochschule Institute of Applied Sciences & Technology, Khyber Pakhtunkhwa, Pakistan.
- Department of Pathology, Islamic International Medical College, Rawalpindi, Pakistan.
Zitieren
APA
Ghulam, B., Afzal, M., Rahim, A., Bashir, Z., Zakria, N., & Abubakr, A. (2024). Molecular profiling of BRCA1/BRCA2 gene variants in Pakistani breast cancer patients. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.11098
Vancouver
Ghulam B, Afzal M, Rahim A, Bashir Z, Zakria N, Abubakr A. Molecular profiling of BRCA1/BRCA2 gene variants in Pakistani breast cancer patients. Journal of the Pakistan Medical Association. 2024. doi:10.47391/jpma.11098
BibTeX
@article{Ghulam2024,
author = {Ghulam, Bushra and Afzal, Muhammad and Rahim, Amena and Bashir, Zahira and Zakria, Naila and Abubakr, Ahmad},
title = {Molecular profiling of BRCA1/BRCA2 gene variants in Pakistani breast cancer patients},
journal = {Journal of the Pakistan Medical Association},
year = {2024},
doi = {10.47391/jpma.11098}
}
EUVIMED